Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-000942

Director gave up 10,558 shares (to pay taxes)

  • Director acquired 17,204 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BRENNAN MURRAY Director 2016-12-30 Grant or award +17,204 63,672 D
BRENNAN MURRAY Director 2016-12-31 Shares withheld for taxes −10,558 $5.35 $56,485 53,114 D
Loading xslF345X03/doc4.xml…